A Zika virus drug being developed by BioCryst Pharmaceuticals is yielding promising results, new research revealed. Scientists tested the drug in a preclinical mice study.
A Zika virus drug being developed by BioCryst Pharmaceuticals is yielding promising results, new research revealed. Scientists tested the drug in a preclinical mice study.
Share this Article
Recommended